Using several AD models, Kim et al. demonstrated AD lesions had increased numbers of IL17A+ ILC3s, which induced IL-33 release by keratinocytes and fibroblasts, promoting type 2 responses and exacerbating disease in mice (154). The gene discussed is IL33; the disease is Alzheimer disease.